Johnson C E, Vigoreaux J A
Am J Hosp Pharm. 1984 Feb;41(2):306-8.
The compatibility of paraldehyde with plastic syringes and needle hubs was evaluated. Paraldehyde, USP, was stored in three types of 5-ml syringes: Plastipak, Glaspak, and all glass; the latter type served as the control. At specified times up to 24 hours, the contents of the syringes was evaporated to constant weight, and the residue was weighed. To evaluate the effect of paraldehyde on plastic needle hubs, needles with plastic and metal hubs were immersed in paraldehyde for 24 hours, and the paraldehyde was evaporated. No measurable change in residue weight was noted in any syringes for up to three hours. Compared with the control, there was a significant increase in the average weight of residue in the Glaspak and in the Plastipak syringes at 6, 12, and 24 hours. There was no significant difference in the weight of residue between the Glaspak and Plastipak syringes at those times, however. The amount of residue for the plastic and metal needle hubs was not significantly different. The source of the extractive residue appeared to be the rubber plunger tip. Since the nature of the extractive material in the residue is not known, paraldehyde should be administered in all-glass syringes if possible; other syringe types can be used only if the drug is administered immediately. The use of needles with plastic hubs is acceptable.
评估了副醛与塑料注射器及针座的兼容性。美国药典级副醛分别储存在三种5毫升注射器中:塑料包装注射器(Plastipak)、玻璃包装注射器(Glaspak)和全玻璃注射器,后者作为对照。在长达24小时的特定时间点,将注射器内的内容物蒸发至恒重,然后对残留物进行称重。为评估副醛对塑料针座的影响,将带有塑料针座和金属针座的针头浸入副醛中24小时,然后将副醛蒸发。在长达三小时的时间里,未观察到任何注射器中的残留物重量有可测量的变化。与对照组相比,在6小时、12小时和24小时时,Glaspak注射器和Plastipak注射器中残留物的平均重量显著增加。然而,在这些时间点,Glaspak注射器和Plastipak注射器中残留物的重量没有显著差异。塑料针座和金属针座的残留物量没有显著差异。萃取残留物的来源似乎是橡胶柱塞头。由于残留物中萃取物质的性质未知,如有可能,副醛应使用全玻璃注射器给药;只有在药物立即给药的情况下,才可使用其他类型的注射器。使用带有塑料针座的针头是可以接受的。